APA Alıntı

Carter, C. A., Degesys, A., Oronsky, B., Scicinski, J., Caroen, S. Z., Oronsky, A. L., . . . Roswarski, J. (2015). Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor. Case Rep Oncol.

Chicago Stili Alıntı

Carter, Corey A., Aiste Degesys, Bryan Oronsky, Jan Scicinski, Scott Z. Caroen, Arnold L. Oronsky, Tony Reid, Pedro Cabrales, ve Joe Roswarski. "Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient With a Treatment-Refractory Neuroendocrine Tumor." Case Rep Oncol 2015.

MLA Alıntı

Carter, Corey A., et al. "Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient With a Treatment-Refractory Neuroendocrine Tumor." Case Rep Oncol 2015.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..